Newsletters

October 2021

Andrew Webb joins as Chief Commercial Officer, BELKIN Vision presents at the ASCRS Innovator's Session and our GLAUrious RCT Study Design is published in the British Journal of Ophthalmology.

Read More
February 2021

Andy Corley joins as Chairman of the Board, EGS Guidelines support laser as first-line treatment and watch our new technology video

Read More
September 2020

Series B closes with $12.25M raised, Introducing the Eagle and Key hires

Read More
February 2020

First-in-Human Trial Completion, Moorfields joins the GLAUrious Trial and Chinese MAB off to a great start

Read More
Skip to content